Annual CFF
$150.36 M
+$148.70 M+8963.35%
December 31, 2023
Summary
- As of February 7, 2025, MGNX annual cash flow from financing activities is $150.36 million, with the most recent change of +$148.70 million (+8963.35%) on December 31, 2023.
- During the last 3 years, MGNX annual CFF has fallen by -$23.98 million (-13.76%).
- MGNX annual CFF is now -26.42% below its all-time high of $204.35 million, reached on December 31, 2015.
Performance
MGNX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$68.00 K
-$693.00 K-110.88%
September 30, 2024
Summary
- As of February 7, 2025, MGNX quarterly cash flow from financing activities is -$68.00 thousand, with the most recent change of -$693.00 thousand (-110.88%) on September 30, 2024.
- Over the past year, MGNX quarterly CFF has dropped by -$341.00 thousand (-124.91%).
- MGNX quarterly CFF is now -100.05% below its all-time high of $140.98 million, reached on September 30, 2015.
Performance
MGNX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$1.08 M
-$49.98 M-97.89%
September 30, 2024
Summary
- As of February 7, 2025, MGNX TTM cash flow from financing activities is $1.08 million, with the most recent change of -$49.98 million (-97.89%) on September 30, 2024.
- Over the past year, MGNX TTM CFF has dropped by -$149.28 million (-99.28%).
- MGNX TTM CFF is now -99.61% below its all-time high of $274.84 million, reached on March 31, 2021.
Performance
MGNX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
MGNX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +8963.4% | -124.9% | -99.3% |
| 3 y3 years | -13.8% | -283.8% | -95.1% |
| 5 y5 years | +43.2% | -283.8% | -95.1% |
MGNX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +8963.4% | -100.1% | at low | -99.3% | at low |
| 5 y | 5-year | -13.8% | +8963.4% | -100.1% | at low | -99.6% | at low |
| alltime | all time | -26.4% | >+9999.0% | -100.0% | at low | -99.6% | +1808.0% |
MacroGenics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$68.00 K(-110.9%) | $1.08 M(-97.9%) |
| Jun 2024 | - | $625.00 K(+152.0%) | $51.06 M(+1.1%) |
| Mar 2024 | - | $248.00 K(-9.2%) | $50.49 M(-66.4%) |
| Dec 2023 | $150.36 M(+8963.4%) | $273.00 K(-99.5%) | $150.36 M(-0.7%) |
| Sep 2023 | - | $49.91 M(>+9900.0%) | $151.45 M(+49.2%) |
| Jun 2023 | - | $59.00 K(-99.9%) | $101.54 M(-0.2%) |
| Mar 2023 | - | $100.12 M(+7267.0%) | $101.74 M(+6032.6%) |
| Dec 2022 | $1.66 M(-98.6%) | $1.36 M(>+9900.0%) | $1.66 M(+50.8%) |
| Sep 2022 | - | $0.00(-100.0%) | $1.10 M(-94.5%) |
| Jun 2022 | - | $263.00 K(+610.8%) | $20.07 M(-9.4%) |
| Mar 2022 | - | $37.00 K(-95.4%) | $22.16 M(-82.0%) |
| Dec 2021 | $122.78 M(-29.6%) | $800.00 K(-95.8%) | $122.78 M(-0.2%) |
| Sep 2021 | - | $18.97 M(+708.7%) | $123.08 M(-30.9%) |
| Jun 2021 | - | $2.35 M(-97.7%) | $178.17 M(-35.2%) |
| Mar 2021 | - | $100.66 M(+9034.1%) | $274.84 M(+57.6%) |
| Dec 2020 | $174.34 M(+45.3%) | $1.10 M(-98.5%) | $174.34 M(+0.5%) |
| Sep 2020 | - | $74.06 M(-25.2%) | $173.54 M(+74.4%) |
| Jun 2020 | - | $99.02 M(>+9900.0%) | $99.51 M(+8714.1%) |
| Mar 2020 | - | $162.00 K(-45.5%) | $1.13 M(-99.1%) |
| Dec 2019 | $119.97 M(+14.3%) | $297.00 K(+702.7%) | $119.97 M(-0.1%) |
| Sep 2019 | - | $37.00 K(-94.2%) | $120.15 M(-0.1%) |
| Jun 2019 | - | $633.00 K(-99.5%) | $120.25 M(-46.2%) |
| Mar 2019 | - | $119.00 M(>+9900.0%) | $223.37 M(+112.7%) |
| Dec 2018 | $104.99 M | $475.00 K(+259.8%) | $104.99 M(+0.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | $132.00 K(-99.9%) | $104.88 M(-1.0%) |
| Jun 2018 | - | $103.75 M(>+9900.0%) | $105.89 M(+195.2%) |
| Mar 2018 | - | $629.00 K(+75.2%) | $35.87 M(+1.5%) |
| Dec 2017 | $35.35 M(+1806.6%) | $359.00 K(-68.7%) | $35.35 M(-0.4%) |
| Sep 2017 | - | $1.15 M(-96.6%) | $35.48 M(+0.4%) |
| Jun 2017 | - | $33.73 M(>+9900.0%) | $35.34 M(+1933.7%) |
| Mar 2017 | - | $108.00 K(-78.0%) | $1.74 M(-6.3%) |
| Dec 2016 | $1.85 M(-99.1%) | $492.00 K(-51.3%) | $1.85 M(+15.0%) |
| Sep 2016 | - | $1.01 M(+696.1%) | $1.61 M(-98.9%) |
| Jun 2016 | - | $127.00 K(-43.3%) | $141.58 M(-0.0%) |
| Mar 2016 | - | $224.00 K(-10.4%) | $141.63 M(-30.7%) |
| Dec 2015 | $204.35 M(+163.9%) | $250.00 K(-99.8%) | $204.35 M(+0.0%) |
| Sep 2015 | - | $140.98 M(>+9900.0%) | $204.32 M(+221.7%) |
| Jun 2015 | - | $170.00 K(-99.7%) | $63.52 M(-0.1%) |
| Mar 2015 | - | $62.95 M(>+9900.0%) | $63.59 M(-17.9%) |
| Dec 2014 | $77.44 M(-9.8%) | $222.00 K(+23.3%) | $77.44 M(-52.3%) |
| Sep 2014 | - | $180.00 K(-24.4%) | $162.24 M(+0.0%) |
| Jun 2014 | - | $238.00 K(-99.7%) | $162.20 M(-0.3%) |
| Mar 2014 | - | $76.80 M(-9.7%) | $162.62 M(+89.4%) |
| Dec 2013 | $85.87 M(>+9900.0%) | $85.02 M(>+9900.0%) | $85.87 M(>+9900.0%) |
| Sep 2013 | - | $142.00 K(-78.2%) | $851.00 K(+20.0%) |
| Jun 2013 | - | $652.50 K(+1054.9%) | $709.00 K(+1154.9%) |
| Mar 2013 | - | $56.50 K | $56.50 K |
| Dec 2012 | $47.00 K(-99.6%) | - | - |
| Dec 2011 | $12.09 M | - | - |
FAQ
- What is MacroGenics annual cash flow from financing activities?
- What is the all time high annual CFF for MacroGenics?
- What is MacroGenics annual CFF year-on-year change?
- What is MacroGenics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for MacroGenics?
- What is MacroGenics quarterly CFF year-on-year change?
- What is MacroGenics TTM cash flow from financing activities?
- What is the all time high TTM CFF for MacroGenics?
- What is MacroGenics TTM CFF year-on-year change?
What is MacroGenics annual cash flow from financing activities?
The current annual CFF of MGNX is $150.36 M
What is the all time high annual CFF for MacroGenics?
MacroGenics all-time high annual cash flow from financing activities is $204.35 M
What is MacroGenics annual CFF year-on-year change?
Over the past year, MGNX annual cash flow from financing activities has changed by +$148.70 M (+8963.35%)
What is MacroGenics quarterly cash flow from financing activities?
The current quarterly CFF of MGNX is -$68.00 K
What is the all time high quarterly CFF for MacroGenics?
MacroGenics all-time high quarterly cash flow from financing activities is $140.98 M
What is MacroGenics quarterly CFF year-on-year change?
Over the past year, MGNX quarterly cash flow from financing activities has changed by -$341.00 K (-124.91%)
What is MacroGenics TTM cash flow from financing activities?
The current TTM CFF of MGNX is $1.08 M
What is the all time high TTM CFF for MacroGenics?
MacroGenics all-time high TTM cash flow from financing activities is $274.84 M
What is MacroGenics TTM CFF year-on-year change?
Over the past year, MGNX TTM cash flow from financing activities has changed by -$149.28 M (-99.28%)